WebOct 21, 2024 · We retrospectively analyzed data of all our pts with locally advanced (LA) or metastatic (M) BTC who received FOLFIRINOX as a first-line therapy from 12/2013 to 11/2024 at Paul Brousse university hospital. The main endpoints were OS, TTP, ORR, DC, secondary resection and toxicity. Results WebTTP, ORR : Bevacizumab in combination with paclitaxel/carboplatin. 1 : Open-label, randomized, active-controlled trial vs. paclitaxel/carboplatin : OS/2006 : Paclitaxel in …
Safety and Efficacy of Camrelizumab Combined with Apatinib for …
WebJun 29, 2024 · PFS, TTP, ORR, and DCR were assessed by the investigator and Independent Review Committee (IRC) according to RECIST 1.1. The final analysis was based on assessment by IRC who were blinded to treatment identity. ORR and DCR were calculated according to confirmed responses (on the basis of two evaluations ≥ 8 weeks apart). Web(1) Background: Cabozantinib is approved in sorafenib-exposed advanced hepatocellular carcinoma (aHCC). We evaluated the real-life pattern of use, efficacy, and tolerability of cabozantinib in aHCC. (2) Methods: This territory-wide study included consecutive aHCC patients who received cabozantinib between February 2024 and September 2024 in Hong … eliafery maron
Effect of cyclo-oxygenase inhibitor use during checkpoint …
WebApr 13, 2024 · As the title suggests, our holding to account policy sets out the tools we’re proposing to use to monitor performance, escalate and investigate issues and if … Web27. On 8 September 2024, ORR wrote to the parties to advise them that it was minded to hear the appeal on the basis that it raised a matter of importance to the industry. … Websubstantiated durable ORR has been used to support traditional approval in select malignancies, but magnitude of effect, relief of tumor-related symptoms, and drug toxicity … foot spa warms water massager